Brainomix brings its artificial intelligence technology to TIPAL trial
Brainomix has partnered with the TIPAL trial group to run a sub-study that will assess the value of its e-Lung platform, an AI-powered image processing module.The TIPAL trial, a placebo-controlled, 52 week multi-centre study,…
Continue Reading